Leah Lawrence
HbA1c variability linked to depression in elderly
Good, long-term control of HbA1c may help prevent depressive symptoms in elderly with type 2 diabetes, according to a new study.
Glucose self-monitoring unnecessary in non-insulin treated diabetics
A lack of improvement in HbA1c compared with patients who monitor glucose indicates that monitoring should not be routine, according to new research.
Long-term commitment to diabetes prevention increases success
Sticking with a prevention program for one year increased the likelihood of success
Telehealth program reduced unneeded diabetic retinopathy referrals
A Los Angeles-based program eliminated 14,000 unnecessary visits to specialty care professionals and reduced wait times for patients in need.
MRI-guided PCa detection strategies found cost-effective
Diagnostic magnetic resonance imaging strategies for the diagnosis of prostate cancer should be considered prior to biopsy of suspicious lesions, according to a recent study.
Residential lifestyle intervention can reduce costs type 2 diabetes costs
Improvements in glycemic control from combined diet and physical activity intervention drove down use of routine medications, according to new study.
Large, early HbA1c reduction lowered risk for CVD events, death
Study: Achieving stringent HbA1c goals within 6 months of initiating metformin predicted decreased risk.
Most men prefer informed decision-making for PCa
Participants in an outreach event for prostate cancer screening preferred education about prostate cancer prior to undergoing screening, and thought the use of an informed decision-making model was beneficial, researchers reported at the Genitourinary Cancers Symposium in Orlando, FL.
18F-choline PET/CT detects PCa recurrences early
Three out of four patients with prostate cancer with an 18F-choline positron emission tomography/computed tomography–detected recurrence were potentially salvageable with local therapy or metastasis-directed therapy (MDT), according to results of the screening phase of the phase II STOMP randomized trial.
USPSTF interventions for CVD risk factors could be cost effective
Targeting all eligible patients would be cost-effective, but cost might be reduced by focusing on certain patient subgroups.